| Abeta | anti-amyloid beta aggregation; |
| AChE | anti-acetylcholinesterase; |
| anti-Aβ | inhibition of amyloid plaque deposits; |
| AoA | antioxidant activity; |
| Asc•− | ascorbyl anion radical; |
| AscH2 | ascorbic acid; |
| AscH• | ascorbyl radical; |
| AscH− | ascorbate anion; |
| CIDNP | chemically induced dynamic nuclear polarization; |
| Dox | Doxorubicin; |
| DpC | di-2-pyridylketone-4-cyclohexyl-4-methyl-3-thiosemicarbazone; |
| DHA | dehydroascorbate; |
| DHP | dihydropyridine; |
| DNA | deoxyribonucleic acid; |
| Dp44mT | di-2-pyridylketone-4,4,-dimethyl-3-thiosemicarbazone; |
| EPR | electron paramagnetic resonance; |
| GSH | glutathione; |
| HL1 | 2-((E)-3-(4-chlorophenyl)-1-phenylallylidene)-N-phenyl-hydrazinecarbothioamide; |
| HL4 | 2-((E)-3-(4-cyanophenyl)-1-phenylallylidene)-N-phenyl-hydrazinecarbothioamide; |
| H2O2 | hydrogen peroxide; |
| H3Ra | H3 receptor antagonism; |
| IND | investigational new drugs; |
| KHP | alpha-ketohydroxypyridines; |
| LA | linoleic acid; |
| logP | octanol/water partition coefficient; |
| L1 | deferiprone; |
| NADH | nicotinamide adenine dinucleotide; |
| NMR | nuclear magnetic resonance; |
| 1O2 | singlet oxygen; |
| OH | hydroxyl radical; |
| OOH | peroxyl radical; |
| Q1 | 2-phenyl-4-(butylamino)naphtho[2,3-h] quinoline-7,12-dione; |
| Q−• | semiquinone radical; |
| RNA | ribonucleic acid; |
| ROS | reactive oxygen species; |
| TSC | thiosemicarbazone; |
| UV-Vis | ultraviolet-visible. |